Skip to main content

Disc Medicine, Inc.

IRON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001816736

In the last 90 days, Disc Medicine, Inc. insiders filed 0 open-market purchases and 9 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $3.13B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Disc Medicine, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of IRON: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders9091+1
Shares19.1M19.9M+764.4K (+4.0%)
Value$848.7M$934.0M+$85.2M (+10.0%)

New holders (19)

Institutions that held Disc Medicine, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to IRON in Q3 2023
InstitutionSharesValue% of portfolio
Paradigm Biocapital Advisors LP1,272,279$59.8M4.08%
Polar Capital Holdings Plc546,915$25.7M0.19%
Victory Capital Management Inc137,523$6.46M0.01%
Rafferty Asset Management, LLC63,132$2.97M0.02%
Hudson Bay Capital Management LP42,000$1.97M0.02%
Goldman Sachs Group Inc27,354$1.29M0.00%
Swiss National Bank17,400$817.5K0.00%
Connor, Clark & Lunn Investment Management Ltd.16,642$781.8K0.00%
Trexquant Investment LP12,534$588.8K0.01%
Jane Street Group, LLC10,649$500.3K0.00%
Profund Advisors LLC10,552$495.7K0.03%
Martingale Asset Management L P9,899$465.1K0.01%
State of Wisconsin Investment Board8,171$383.9K0.00%
Credit Suisse AG6,136$288.3K0.00%
Squarepoint Ops LLC5,200$244.3K0.00%
STRS Ohio600$28.0K0.00%
Allspring Global Investments Holdings, LLC232$10.9K0.00%
Nisa Investment Advisors, LLC9$4230.00%
Covestor Ltd2$00.00%

Sold out (18)

Institutions that held Disc Medicine, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.